Santa Clara, California-based Agilent Technologies, Inc. (A) provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. Valued at a market cap of $40.8 billion, the company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets.
Companies with a market cap of $10 billion or more are typically referred to as “large-cap stocks.” A fits perfectly into that category, with its market cap exceeding this threshold and reflecting its substantial size and influence in the diagnostics and research industry.